TNF and systemic lupus erythematosus: Because most cases were observed in patients with RA or SLE, it will be interesting to focus on these two AIDs, by conducting a large prospective study on the prevalence of Toxoplasma disease and identification of specific risk factors, possibly antimetabolite conventional treatments (methotrexate, azathioprine or MMF) or biologics (like anti-TNF-α).